Investment analysts at StockNews.com assumed coverage on shares of Calithera Biosciences (NASDAQ:CALA – Get Free Report) in a report released on Saturday. The brokerage set a “hold” rating on the biotechnology company’s stock.
Calithera Biosciences Price Performance
Shares of CALA stock opened at $0.00 on Friday. Calithera Biosciences has a 1 year low of $0.00 and a 1 year high of $0.12.
About Calithera Biosciences
Featured Articles
- Five stocks we like better than Calithera Biosciences
- Canadian Penny Stocks: Can They Make You Rich?
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- Best Stocks Under $10.00
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- High Dividend REITs: Are They an Ideal Way to Diversify?
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year
Receive News & Ratings for Calithera Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calithera Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
